Number of the records: 1  

Recombinant interleukin-2 acts as an adjuvant and helps to increase the efficacy of tumour vaccines

  1. 1.
    0190366 - UMG-J 970033 RIV CZ eng J - Journal Article
    Vondrys, Pavel - Šímová, Jana - Takáčová, Šárka - Jandlová, Táňa - Bubeník, Jan
    Recombinant interleukin-2 acts as an adjuvant and helps to increase the efficacy of tumour vaccines.
    Folia Biologica. Roč. 43, č. 1 (1997), s. 39-40. ISSN 0015-5500. E-ISSN 0015-5500
    R&D Projects: GA AV ČR IAA7052501; GA ČR GA312/95/0137; GA MZd IZ3516
    Impact factor: 0.522, year: 1997
    Permanent Link: http://hdl.handle.net/11104/0086149

     
     

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.